Metagenomi Inc (NASDAQ:MGX) currently has a daily average trading volume of 1.68M but it saw 1900037 shares traded in last market. With a market cap of 144.46M USD, the company’s current market price of $3.86 came rising about 24.12 while comparing to the previous closing price of $3.11. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.74 and as low as $1.61. In the recent trading on the day, stock has struck highest price mark of $3.22 while lowest mark touched by it was $3.88.
Taking a look at 20-day trading activity of Metagenomi Inc (MGX) gives us an average price of $2.72, while its current price level is -69.70% below from 52-week high level whereas it is 139.75% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.27 while that of 200 days or SMA-200 reads an average of $4.81. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.15% during that period while stretching the period over a month that decreases to 16.53%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 65.61 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on May 07, 2024, recommending a price target of $10 for it. JP Morgan downgraded its recommendation for the stock as a “Neutral” from “Overweight” on May 02, 2024 while assigning a price target range of $16-$6. Wells Fargo also issued its recommendations for the stock as it initiated the price target for the stock is $25.
Year-to-date it is -62.56% down and over the past year.
Currently, Metagenomi Inc’s total number of outstanding shares is 37.43M. Company’s return on investment (ROI) stands at -24.89% and return on equity (ROE) at -30.34%. Stock has a price to book (P/B) ratio of 0.56 while price to sale or P/S ratio amounts to 2.62. Its return on asset (ROA) is -19.86% on average.
